scispace - formally typeset
Open AccessJournal ArticleDOI

Pro-resolving lipid mediators are leads for resolution physiology

Charles N. Serhan
- 05 Jun 2014 - 
- Vol. 510, Iss: 7503, pp 92-101
Reads0
Chats0
TLDR
The mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions are covered.
Abstract
Advances in our understanding of the mechanisms that bring about the resolution of acute inflammation have uncovered a new genus of pro-resolving lipid mediators that include the lipoxin, resolvin, protectin and maresin families, collectively called specialized pro-resolving mediators. Synthetic versions of these mediators have potent bioactions when administered in vivo. In animal experiments, the mediators evoke anti-inflammatory and novel pro-resolving mechanisms, and enhance microbial clearance. Although they have been identified in inflammation resolution, specialized pro-resolving mediators are conserved structures that also function in host defence, pain, organ protection and tissue remodelling. This Review covers the mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis.

TL;DR: Intracacanal treatment with Resolvin D2 resolves inflammation and promoting calcification around root apex and healing of periapical bone lesions, suggesting that the data suggest that RvD2 induces active resolution of inflammation with pulp-like tissue regeneration after root canal infection and thus maybe suitable for treating periAPical lesions.
Journal ArticleDOI

Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages

TL;DR: Support is presented for the apprehended biosynthesis of 1 in human macrophages occurring via the intermediate 16S,17S-epoxyprotectin (5), based on results from LC/MS-MS metabololipidomics.
Journal ArticleDOI

An overview on recent in vivo biological application of cerium oxide nanoparticles.

TL;DR: In vivo anti-cancer studies revealed the effectiveness of CNPs to reduce tumor growth and angiogenesis in melanoma, ovarian, breast and retinoblastoma cancer cell-induced mice, with their conjugation with folic acid, doxorubicin, CPM, or CXC receptor-4 antagonist ligand eliciting higher efficiency.
Journal ArticleDOI

Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes

TL;DR: It is concluded that patients with CHF show alterations in producing proresolving mediator RvD1 and a failure of adaptive immune cells in responding to the anti‐inflammatory actions of RvDs that may contribute to the progression of chronic inflammation.
Journal ArticleDOI

Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.

TL;DR: It is shown here for the first time that the impaired left ventricular systolic contractility in experimental sepsis is attenuated by FTY720, and Mechanistically, the results indicate that activation of S1P2 by increased serum S 1P and the subsequent activation of the PI3K-Akt survival pathway significantly contributes to the observed cardioprotective effect of FTY 720.
References
More filters
Journal ArticleDOI

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

TL;DR: A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention and provide a paradigm for macrophage plasticity and function.
Journal ArticleDOI

Resolution of inflammation: the beginning programs the end.

TL;DR: Emerging evidence now suggests that an active, coordinated program of resolution initiates in the first few hours after an inflammatory response begins, and the mechanism required for inflammation resolution may underpin the development of drugs that can resolve inflammatory processes in directed and controlled ways.
Journal ArticleDOI

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

TL;DR: It is reported that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid produce a novel family of bioactive 17R-hydroxy-containing di- and tri-Hydroxy-docosanoids termed resolvins.
Journal ArticleDOI

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

TL;DR: Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained reduction in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.
Related Papers (5)